UK markets open in 6 hours 35 minutes
NIKKEI 225
27,360.89 -1.86 (-0.01%) HANG SENG
22,566.78 0.00 (0.00%) CRUDE OIL
81.28 +0.27 (+0.33%) GOLD FUTURES
1,933.10 +3.10 (+0.16%) DOW
33,949.41 +205.57 (+0.61%) BTC-GBP
18,507.44 -279.44 (-1.49%)
Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Loading interactive chart…
- Motley Fool
Is Biogen Stock a Buy Now?
Moving new medicines to the market can sometimes make biopharmaceutical companies tons of returns. Biogen (NASDAQ: BIIB) just scored a major new drug approval for an Alzheimer's disease therapy, so investors are understandably rushing to evaluate whether to buy the stock. One key factor that could drive Biogen's outperformance in the next few years is the launch of a new neurology medicine.
- Motley Fool
Is Biogen Stock a No-Brainer Buy After Eli Lilly's Alzheimer's Disease Setback?
Lilly's FDA rejection puts Biogen and its partner Eisai in the driver's seat in the Alzheimer's disease drug market.
- Zacks
Biogen Inc. (BIIB) Stock Moves -0.02%: What You Should Know
In the latest trading session, Biogen Inc. (BIIB) closed at $291.88, marking a -0.02% move from the previous day.
© 2023 Yahoo. All rights reserved.
